Xenobiotic efflux in bacteria and fungi: A genomics update

Advances in Enzymology and Related Areas of Molecular Biology

Volumn 77 1, Issue , 2010, Pages 237-306

  Barabote, Ravi D ^a   Thekkiniath, Jose ^b   Strauss, Richard E ^b   Vediyappan, Govindsamy ^c   Fralick, Joe A ^c   Francisco, Michael J San ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TEXAS TECH UNIVERSITY   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CARRIER PROTEIN; XENOBIOTIC AGENT;

BACTERIAL GENE; BACTERIAL GENOME; BACTERIUM; BIOFILM; CHEMISTRY; FUNGAL GENE; FUNGUS; GENE EXPRESSION REGULATION; GENETICS; GENOMICS; HUMAN; PHYLOGENY; REVIEW; SPECIES DIFFERENCE; TRANSPORT AT THE CELLULAR LEVEL;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BACTERIA; BIOFILMS; BIOLOGICAL TRANSPORT; FUNGI; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; GENES, FUNGAL; GENOME, BACTERIAL; GENOMICS; HUMANS; MEMBRANE TRANSPORT PROTEINS; PHYLOGENY; SPECIES SPECIFICITY; XENOBIOTICS;

EID: 79960959945     PISSN: 0065258X     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (321)

1. Fischbach, M. A., and Walsh, C. T. (2009) Antibiotics for emerging pathogens, Science 325, 1089-1093.
2. McMurry, L., Petrucci, R., and Levy, S. (1980) Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli, Proc. Natl. Acad. Sci. USA 77, 3974-3977.
3. Paulsen, I. T. (2003) Multidrug efflux pumps and resistance: regulation and evolution, Curr. Opin. Microbiol. 6, 446-451.
4. Alonso, A., Rojo, F., and Martínez, J. L. (1999) Environmental and clinical isolates of Pseudomonas aeruginosa show pathogenic and biodegradative properties irrespective of their origin, Environ. Microbiol. 1, 421-430.
5. Grkovic, S., Brown, M. H., and Skurray, R. A. (2002) Regulation of bacterial drug export systems, Microbiol. Mol. Biol. Rev. 66, 671-701.
6. Martínez, J. L., Sánchez, M. B., Martinez-Solano, L., Hernández, A., Garmendia, L., Fajardo, A., and Alvarez-Ortega, C. (2009) Functional role of bacterial multidrug efflux pumps in microbial natural ecosystems, FEMS Microbiol. Rev. 33, 430-449.
7. Paulsen, I.T., Skurray,R.A.,Tam, R., Saier, M.H., Jr.,Turner, R. J.,Weiner, J.H.,Goldberg, E. B., and Grinius, L.L. (1996)TheSMRfamily: a novel family ofmultidrug efflux proteins involved with the efflux of lipophilic drugs, Mol. Microbiol. 19, 1167-1175.
8. Brown, M. H., Paulsen, I. T., and Skurray, R. A. (1999) The multidrug efflux protein NorM is a prototype of a new family of transporters, Mol. Microbiol. 31, 394-395.
9. Hvorup, R. N., Winnen, B., Chang, A. B., Jiang, Y., Zhou, X. F., and Saier, M. H., Jr. (2003) The multidrug/oligosaccharidyl-lipid/polysaccharide (MOP) exporter superfamily, Eur. J. Biochem. 270, 799-813.
10. Marger, M. D., and Saier, M. H., Jr. (1993) A major superfamily of transmembrane facilitators that catalyse uniport, symport and antiport, Trends Biochem. Sci. 18, 13-20.
11. Saier, M. H., Jr., Tam, R., Reizer, A., and Reizer, J. (1994) Two novel families of bacterial membrane proteins concerned with nodulation, cell division and transport, Mol. Microbiol. 11, 841-847.
12. Lubelski, J., Konings, W. N., and Driessen, A. J. (2007) Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria, Microbiol. Mol. Biol. Rev. 71, 463-476.
13. Saier, M. H., Jr., and Paulsen, I. T. (2001) Phylogeny of multidrug transporters, Semin. Cell Dev. Biol. 12, 205-213.
14. Saier, M. H., Jr. (2000) A functional-phylogenetic classification system for transmembrane solute transporters, Microbiol. Mol. Biol. Rev. 64, 354-411.
15. Pao, S. S., Paulsen, I. T., and Saier, M. H., Jr. (1998) Major facilitator superfamily, Microbiol. Mol. Biol. Rev. 62, 1-34.
16. Paulsen, I. T., Brown, M. H., and Skurray, R. A. (1996) Proton-dependent multidrug efflux systems, Microbiol. Rev. 60, 575-608.
17. Saier, M. H., Jr., Beatty, J. T., Goffeau, A., Harley, K. T., Heijne, W. H., Huang, S. C., Jack, D. L., Jahn, P. S., Lew, K., Liu, J., et al. (1999) The major facilitator superfamily, J. Mol. Microbiol. Biotechnol. 1, 257-279.
18. Li, X. Z., and Nikaido, H. (2004) Efflux-mediated drug resistance in bacteria, Drugs 64, 159-204.
19. Putman, M., van Veen, H. W., and Konings, W. N. (2000) Molecular properties of bacterial multidrug transporters, Microbiol. Mol. Biol. Rev. 64, 672-693.
20. Saier, M. H., Jr., Yen, M. R., Noto, K., Tamang, D. G., and Elkan, C. (2009) The Transporter Classification Database: recent advances, Nucleic Acids Res. 37, D274-D278.
21. Van Bambeke, F., Glupczynski, Y., Plé, P., Pechere, J. C., and Tulkens, P. M. (2003) Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy, J. Antimicrob. Chemother. 51, 1055-1065.
22. Lynch, A. S. (2006) Efflux systems in bacterial pathogens: an opportunity for therapeutic intervention? An industry view, Biochem. Pharmacol. 71, 949-956.
23. Chen, C. J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., and Roninson, I. B. (1986) Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells, Cell 47, 381-389.
24. Gottesman, M. M., Pastan, I., and Ambudkar, S. V. (1996) P-glycoprotein and multidrug resistance, Curr. Opin. Genet. Dev. 6, 610-617.
25. Cole,S.P.,Bhardwaj,G.,Gerlach, J.H.,Mackie, J.E., Grant, C. E.,Almquist,K. C., Stewart, A. J., Kurz, E. U., Duncan, A.M., and Deeley, R.G. (1992)Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line, Science 258, 1650-1654.
26. Legare, D., Cayer, S., Singh, A. K., Richard, D., Papadopoulou, B., and Ouellette, M. (2001) ABC proteins of Leishmania, J. Bioenerg. Biomembr. 33, 469-474.
27. van Veen, H. W., Venema, K., Bolhuis, H., Oussenko, I., Kok, J., Poolman, B., Driessen, A. J., and Konings, W. N. (1996) Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1, Proc. Natl. Acad. Sci. USA 93, 10668-10672.
28. Robertson, G. T., Doyle, T. B., and Lynch, A. S. (2005) Use of an efflux-deficient Streptococcus pneumoniae strain panel to identify ABC-class multidrug transporters involved in intrinsic resistance to antimicrobial agents, Antimicrob. Agents Chemother. 49, 4781-4783.
29. Piddock, L. J. (2006) Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria, Clin. Microbiol. Rev. 19, 382-402.
30. van Veen, H.W.,Margolles, A., Muller,M., Higgins, C. F., and Konings,W. N. (2000) The homodimeric ATP-binding cassette transporter LmrA mediates multidrug transport by an alternating two-site (two-cylinder engine) mechanism, EMBO J. 19, 2503-2514.
31. Rosenberg, M. F., Callaghan, R., Ford, R. C., and Higgins, C. F. (1997) Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis, J. Biol. Chem. 272, 10685-10694.
32. van Veen, H.W., Higgins, C. F., and Konings,W. N. (2001) Molecular basis of multidrug transport by ATP-binding cassette transporters: a proposed two-cylinder engine model, J. Mol. Microbiol. Biotechnol. 3, 185-192.
33. Procko, E., O'Mara, M. L., Bennett, W. F., Tieleman, D. P., and Gaudet, R. (2009) The mechanism of ABC transporters: general lessons from structural and functional studies of an antigenic peptide transporter, FASEB J. 23, 1287-1302.
34. Murakami, S., and Yamaguchi, A. (2003) Multidrug-exporting secondary transporters, Curr. Opin. Struct. Biol. 13, 443-452.
35. Lin, H. T., Bavro, V. N., Barrera, N. P., Frankish, H. M., Velamakanni, S., van Veen, H.W., Robinson, C. V., Borges-Walmsley, M. I., andWalmsley, A. R. (2009) MacB ABC transporter is a dimer whose ATPase activity and macrolide-binding capacity are regulated by the membrane fusion protein MacA, J. Biol. Chem. 284, 1145-1154.
36. Schmitz, F. J., Sadurski, R., Kray, A., Boos, M., Geisel, R., Kohrer, K., Verhoef, J., and Fluit, A. C. (2000) Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals, J. Antimicrob. Chemother. 45, 891-894.
37. Portillo, A., Ruiz-Larrea, F., Zarazaga, M., Alonso, A., Martínez, J. L., and Torres, C. (2000) Macrolide resistance genes in Enterococcus spp., Antimicrob. Agents Chemother. 44, 967-971.
38. Pozzi, G., Iannelli, F., Oggioni, M. R., Santagati, M., and Stefani, S. (2004) Genetic elements carrying macrolide efflux genes in streptococci, Curr. Drug Targets Infect. Disord. 4, 203-206.
39. Daly, M. M., Doktor, S., Flamm, R., and Shortridge, D. (2004) Characterization and prevalence of MefA, MefE, and the associated msr(D) gene in Streptococcus pneumoniae clinical isolates, J. Clin. Microbiol. 42, 3570-3574.
40. Reynolds, E.,Ross, J. I., and Cove, J.H. (2003)Msr(A) and relatedmacrolide/streptogramin resistance determinants: incomplete transporters? Int. J. Antimicrob. Agents 22, 228-236.
41. Dina, J., Malbruny, B., and Leclercq, R. (2003) Nonsense mutations in the lsa-like gene in Enterococcus faecalis isolates susceptible to lincosamides and streptogramins A, Antimicrob. Agents Chemother. 47, 2307-2309.
42. Lee, E. W., Huda, M. N., Kuroda, T., Mizushima, T., and Tsuchiya, T. (2003) EfrAB, an ABC multidrug efflux pump in Enterococcus faecalis, Antimicrob. Agents Chemother. 47, 3733-3738.
43. Kehrenberg, C., Ojo, K. K., and Schwarz, S. (2004) Nucleotide sequence and organization of the multiresistance plasmid pSCFS1 from Staphylococcus sciuri, J. Antimicrob. Chemother. 54, 936-939.
44. Kobayashi, N., Nishino, K., and Yamaguchi, A. (2001) Novel macrolide-specific ABC-type efflux transporter in Escherichia coli, J. Bacteriol. 183, 5639-5644.
45. Poelarends, G. J., Mazurkiewicz, P., and Konings, W. N. (2002) Multidrug transporters and antibiotic resistance in Lactococcus lactis, Biochim. Biophys. Acta 1555, 1-7.
46. Huda, N., Lee, E. W., Chen, J., Morita, Y., Kuroda, T., Mizushima, T., and Tsuchiya, T. (2003) Molecular cloning and characterization of an ABC multidrug efflux pump, VcaM, in Non-O1 Vibrio cholerae, Antimicrob. Agents Chemother. 47, 2413-2417.
47. Pasca, M. R., Guglierame, P., Arcesi, F., Bellinzoni, M., De Rossi, E., and Riccardi, G. (2004) Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis, Antimicrob. Agents Chemother. 48, 3175-3178.
48. Raherison, S., Gonzalez, P., Renaudin, H., Charron, A., Bebear, C., and Bebear, C. M. (2005) Increased expression of two multidrug transporter-like genes is associated with ethidium bromide and ciprofloxacin resistance in Mycoplasma hominis, Antimicrob. Agents Chemother. 49, 421-424.
49. Muth, T. R., and Schuldiner, S. (2000) A membrane-embedded glutamate is required for ligand binding to the multidrug transporter EmrE, EMBO J. 19, 234-240.
50. Gutman, N., Steiner-Mordoch, S., and Schuldiner, S. (2003) An amino acid cluster around the essential Glu-14 is part of the substrate- and proton-binding domain of EmrE, a multidrug transporter from Escherichia coli, J. Biol. Chem. 278, 16082-16087.
51. Koteiche, H. A., Reeves, M. D., and McHaourab, H. S. (2003) Structure of the substrate binding pocket of the multidrug transporter EmrE: site-directed spin labeling of transmembrane segment 1, Biochemistry 42, 6099-6105.
52. Schuldiner, S., Granot, D., Mordoch, S. S., Ninio, S., Rotem, D., Soskin, M., Tate, C. G., and Yerushalmi, H. (2001) Small is mighty: EmrE, a multidrug transporter as an experimental paradigm, News Physiol. Sci. 16, 130-134.
53. Soskine, M., Steiner-Mordoch, S., and Schuldiner, S. (2002) Crosslinking of membraneembedded cysteines reveals contact points in the EmrE oligomer, Proc. Natl. Acad. Sci. USA 99, 12043-12048.
54. Leelaporn, A., Paulsen, I. T., Tennent, J. M., Littlejohn, T. G., and Skurray, R. A. (1994) Multidrug resistance to antiseptics and disinfectants in coagulase-negative. staphylococci, J. Med. Microbiol. 40, 214-220.
55. Grinius, L., Dreguniene, G., Goldberg, E. B., Liao, C. H., and Projan, S. J. (1992) A staphylococcal multidrug resistance gene product is a member of a new protein family, Plasmid 27, 119-129.
56. Littlejohn, T. G., Paulsen, I. T., Gillespie, M. T., Tennent, J. M., Midgley, M., Jones, I. G., Purewal, A. S., and Skurray, R. A. (1992) Substrate specificity and energetics of antiseptic and disinfectant resistance in Staphylococcus aureus, FEMSMicrobiol. Lett. 74, 259-265.
57. Lewis, K. (1994) Multidrug resistance pumps in bacteria: variations on a theme, Trends Biochem. Sci. 19, 119-123.
58. Masaoka, Y., Ueno, Y., Morita, Y., Kuroda, T., Mizushima, T., and Tsuchiya, T. (2000) A two-component multidrug efflux pump, EbrAB, in Bacillus subtilis, J. Bacteriol. 182, 2307-2310.
59. Ninio, S., Rotem, D., and Schuldiner, S. (2001) Functional analysis of novel multidrug transporters from human pathogens, J. Biol. Chem. 276, 48250-48256.
60. Rotem, D., Sal-man, N., and Schuldiner, S. (2001) In vitro monomer swapping in EmrE, a multidrug transporter from Escherichia coli, reveals that the oligomer is the functional unit, J. Biol. Chem. 276, 48243-48249.
61. Rotem, D., and Schuldiner, S. (2004) EmrE, a multidrug transporter from Escherichia coli, and transports monovalent and divalent substrates with the same stoichiometry, J. Biol. Chem. 279, 48787-48793.
62. Li,X. Z., Zhang, L., andNikaido,H. (2004) Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis, Antimicrob. Agents Chemother. 48, 2415-2423.
63. + and is soluble in organic solvents, J. Biol. Chem. 270, 6856-6863.
64. Jack, D. L., Storms, M. L., Tchieu, J. H., Paulsen, I. T., and Saier, M. H., Jr. (2000) A broad-specificity multidrug efflux pump requiring a pair of homologous SMR-type proteins, J. Bacteriol. 182, 2311-2313.
65. Li, X. Z., Poole, K., and Nikaido, H. (2003) Contributions of MexAB-OprM and an EmrE homolog to intrinsic resistance of Pseudomonas aeruginosa to aminoglycosides and dyes, Antimicrob. Agents Chemother. 47, 27-33.
66. Kucken, D., Feucht, H., and Kaulfers, P. (2000) Association of qacE and qacEDelta1 with multiple resistance to antibiotics and antiseptics in clinical isolates of gram-negative bacteria, FEMS Microbiol. Lett. 183, 95-98.
67. Omote, H., Hiasa, M., Matsumoto, T., Otsuka, M., and Moriyama, Y. (2006) The MATE proteins as fundamental transporters of metabolic and xenobiotic organic cations, Trends Pharmacol. Sci. 27, 587-593.
68. Morita, Y., Kodama, K., Shiota, S., Mine, T., Kataoka, A., Mizushima, T., and Tsuchiya, T. (1998) NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli, Antimicrob. Agents Chemother. 42, 1778-1782.
69. Kuroda, T., and Tsuchiya, T. (2009) Multidrug efflux transporters in the MATE family, Biochim. Biophys. Acta 1794, 763-768.
70. +.-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters, Antimicrob. Agents Chemother. 49, 4362-4364.
71. McAleese, F., Petersen, P., Ruzin, A., Dunman, P. M., Murphy, E., Projan, S. J., and Bradford, P. A. (2005) A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline, Antimicrob. Agents Chemother. 49, 1865-1871.
72. Long, F., Rouquette-Loughlin, C., Shafer,W. M., and Yu, E.W. (2008) Functional cloning and characterization of the multidrug efflux pumps NorMfrom Neisseria gonorrhoeae and YdhE from Escherichia coli, Antimicrob. Agents Chemother. 52, 3052-3060.
73. Rouquette-Loughlin, C., Dunham, S. A., Kuhn, M., Balthazar, J. T., and Shafer, W. M. (2003) The NorM efflux pump of Neisseria gonorrhoeae and Neisseria meningitidis recognizes antimicrobial cationic compounds, J. Bacteriol. 185, 1101-1106.
74. Kaatz, G. W., McAleese, F., and Seo, S. M. (2005) Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein, Antimicrob. Agents Chemother. 49, 1857-1864.
75. Yang, S., Clayton, S. R., and Zechiedrich, E. L. (2003) Relative contributions of the AcrAB, MdfA and NorE efflux pumps to quinolone resistance in Escherichia coli, J. Antimicrob. Chemother. 51, 545-556.
76. Miyamae, S., Ueda, O., Yoshimura, F., Hwang, J., Tanaka, Y., and Nikaido, H. (2001) A MATE family multidrug efflux transporter pumps out fluoroquinolones in Bacteroides thetaiotaomicron, Antimicrob. Agents Chemother. 45, 3341-3346.
77. Xu, X. J., Su, X. Z., Morita, Y., Kuroda, T., Mizushima, T., and Tsuchiya, T. (2003) Molecular cloning and characterization of the HmrM multidrug efflux pump from Haemophilus influenzae Rd, Microbiol. Immunol. 47, 937-943.
78. He, G. X., Kuroda, T., Mima, T., Morita, Y., Mizushima, T., and Tsuchiya, T. (2004) An H(+)-coupled multidrug efflux pump, PmpM, a member of the MATE family of transporters, from Pseudomonas aeruginosa, J. Bacteriol. 186, 262-265.
79. Chen, J., Morita, Y., Huda, M. N., Kuroda, T., Mizushima, T., and Tsuchiya, T. (2002) VmrA, a member of a novel class of Na(+)-coupled multidrug efflux pumps from Vibrio parahaemolyticus, J. Bacteriol. 184, 572-576.
80. Dridi, L., Tankovic, J., and Petit, J. C. (2004) CdeA of Clostridium difficile, a new multidrug efflux transporter of the MATE family, Microb. Drug Resist. 10, 191-196.
81. + -driven multidrug efflux pump VcmA from Vibrio cholerae non-O1, a non-halophilic bacterium, FEMS Microbiol. Lett. 203, 235-239.
82. + -coupled multidrug efflux pump, from Vibrio cholerae non-O1, Microbiol. Immunol. 47, 419-427.
83. Begum, A., Rahman, M. M., Ogawa, W., Mizushima, T., Kuroda, T., and Tsuchiya, T. (2005) Gene cloning and characterization of four MATE family multidrug efflux pumps from Vibrio cholerae non-O1, Microbiol. Immunol. 49, 949-957.
84. Nishino, K., Latifi, T., and Groisman, E. A. (2006) Virulence and drug resistance roles of multidrug efflux systems of Salmonella enterica serovar typhimurium, Mol. Microbiol. 59, 126-141.
85. Saier, M. H., Jr. (2003) Tracing pathways of transport protein evolution, Mol. Microbiol. 48, 1145-1156.
86. Ren, Q., and Paulsen, I. T. (2007) Large-scale comparative genomic analyses of cytoplasmic membrane transport systems in prokaryotes, J. Mol. Microbiol. Biotechnol. 12, 165-179.
87. Maloney, P. C. (1990) Microbes and membrane biology, FEMS Microbiol. Rev. 7, 91-102.
88. Yin, Y., He, X., Szewczyk, P., Nguyen, T., and Chang, G. (2006) Structure of the multidrug transporter EmrD from Escherichia coli, Science 312, 741-744.
89. Huang, Y., Lemieux, M. J., Song, J., Auer, M., and Wang, D. N. (2003) Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli, Science 301, 616-620.
90. Abramson, J., Smirnova, I., Kasho, V., Verner, G., Kaback, H. R., and Iwata, S. (2003) Structure and mechanism of the lactose permease of Escherichia coli, Science 301, 610-615.
91. Woolley, R. C., Vediyappan, G., Anderson, M., Lackey, M., Ramasubramanian, B., Jiangping, B., Borisova, T., Colmer, J. A., Hamood, A. N., McVay, C. S., and Fralick, J. A. (2005) Characterization of the Vibrio cholerae vceCAB multiple-drug resistance efflux operon in Escherichia coli, J. Bacteriol. 187, 5500-5503.
92. Colmer, J. A., Fralick, J. A., and Hamood, A. N. (1998) Isolation and characterization of a putative multidrug resistance pump from Vibrio cholerae, Mol. Microbiol. 27, 63-72.
93. Lomovskaya, O., and Lewis, K. (1992) Emr, an Escherichia coli locus for multidrug resistance, Proc. Natl. Acad. Sci. USA 89, 8938-8942.
94. Tanabe, M., Szakonyi, G., Brown, K. A., Henderson, P. J., Nield, J., and Byrne, B. (2009) The multidrug resistance efflux complex, EmrAB from Escherichia coli forms a dimer in vitro, Biochem. Biophys. Res. Commun. 380, 338-342.
95. Schwarz, S., Kehrenberg, C., Doublet, B., and Cloeckaert, A. (2004) Molecular basis of bacterial resistance to chloramphenicol and florfenicol,FEMSMicrobiol. Rev. 28, 519-542.
96. Haroche, J., Morvan, A., Davi, M., Allignet, J., Bimet, F., and El Solh, N. (2003) Clonal diversity among streptogramin A-resistant Staphylococcus aureus isolates collected in French hospitals, J. Clin. Microbiol. 41, 586-591.
97. Poole, K. (2000) Efflux-mediated resistance to fluoroquinolones in gram-positive bacteria and the mycobacteria, Antimicrob. Agents Chemother. 44, 2595-2599.
98. Gill, M. J., Brenwald, N. P., and Wise, R. (1999) Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae, Antimicrob. Agents Chemother. 43, 187-189.
99. Poole, K. (2004) Efflux-mediated multiresistance in gram-negative bacteria, Clin. Microbiol. Infect. 10, 12-26.
100. Poole, K. (2005) Efflux-mediated antimicrobial resistance, J. Antimicrob. Chemother. 56, 20-51.
101. Tanabe, H., Yamasak, K., Furue, M., Yamamoto, K., Katoh, A., Yamamoto, M., Yoshioka, S., Tagami, H., Aiba, H. A., and Utsumi, R. (1997) Growth phase-dependent transcription of emrKY, a homolog of multidrug efflux emrAB genes of Escherichia coli, is induced by tetracycline, J. Gen. Appl. Microbiol. 43, 257-263.
102. Jonas, B. M., Murray, B. E., and Weinstock, G. M. (2001) Characterization of emeA, a NorA homolog and multidrug resistance efflux pump, in Enterococcus faecalis, Antimicrob. Agents Chemother. 45, 3574-3579.
103. Lee, E. W., Chen, J., Huda, M. N., Kuroda, T., Mizushima, T., and Tsuchiya, T. (2003) Functional cloning and expression of emeA, and characterization of EmeA, a multidrug efflux pump from Enterococcus faecalis, Biol. Pharm. Bull. 26, 266-270.
104. Godreuil, S., Galimand, M., Gerbaud, G., Jacquet, C., and Courvalin, P. (2003) Efflux pump Lde is associated with fluoroquinolone resistance in Listeria monocytogenes, Antimicrob. Agents Chemother. 47, 704-708.
105. Ohki, R., and Murata, M. (1997) bmr3, a third multidrug transporter gene of Bacillus subtilis, J. Bacteriol. 179, 1423-1427.
106. Borges-Walmsley, M. I., McKeegan, K. S., and Walmsley, A. R. (2003) Structure and function of efflux pumps that confer resistance to drugs, Biochem. J. 376, 313-338.
107. Yoshida, H., Bogaki, M., Nakamura, S., Ubukata, K., and Konno, M. (1990) Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones, J. Bacteriol. 172, 6942-6949.
108. Truong-Bolduc, Q. C., Dunman, P. M., Strahilevitz, J., Projan, S. J., and Hooper, D. C. (2005) MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureus, J. Bacteriol. 187, 2395-2405.
109. Huang, J., O'Toole, P.W., Shen,W., Amrine-Madsen, H., Jiang, X., Lobo, N., Palmer, L. M., Voelker, L., Fan, F., Gwynn, M. N., and McDevitt, D. (2004) Novel chromosomally encoded multidrug efflux transporter MdeA in Staphylococcus aureus, Antimicrob. Agents Chemother. 48, 909-917.
110. Mitchell, B. A., Paulsen, I. T., Brown, M. H., and Skurray, R. A. (1999) Bioenergetics of the staphylococcal multidrug export protein QacA: identification of distinct binding sites for monovalent and divalent cations, J. Biol. Chem. 274, 3541-3548.
111. Kim, H. J., Kim, Y., Lee, M. S., and Lee, H. S. (2001) Gene lmrB of Corynebacterium glutamicum confers efflux-mediated resistance to lincomycin, Mol. Cells 12, 112-116.
112. Murata, M., Ohno, S., Kumano, M., Yamane, K., and Ohki, R. (2003) Multidrug resistant phenotype of Bacillus subtilis spontaneous mutants isolated in the presence of puromycin and lincomycin, Can. J. Microbiol. 49, 71-77.
113. Kumano, M., Fujita, M., Nakamura, K., Murata, M., Ohki, R., and Yamane, K. (2003) Lincomycin resistance mutations in two regions immediately downstream of the -10 region of lmr promoter cause overexpression of a putative multidrug efflux pump in Bacillus subtilis mutants, Antimicrob. Agents Chemother. 47, 432-435.
114. Lebel, S., Bouttier, S., and Lambert, T. (2004) The cme gene of Clostridium difficile confers multidrug resistance in Enterococcus faecalis, FEMS Microbiol. Lett. 238, 93-100.
115. Roberts, M. C. (1996) Tetracycline resistance determinants: mechanisms of action, regulation of expression, geneticmobility, and distribution,FEMSMicrobiol. Rev. 19, 1-24.
116. Butaye, P., Cloeckaert, A., and Schwarz, S. (2003) Mobile genes coding for effluxmediated antimicrobial resistance in gram-positive and gram-negative bacteria, Int. J. Antimicrob. Agents 22, 205-210.
117. Agerso, Y., and Guardabassi, L. (2005) Identification of Tet 39, a novel class of tetracycline resistance determinant in Acinetobacter spp. of environmental and clinical origin, J. Antimicrob. Chemother. 55, 566-569.
118. Ainsa, J. A., Blokpoel, M. C., Otal, I., Young, D. B., De Smet, K. A., andMartin, C. (1998) Molecular cloning and characterization of Tap, a putative multidrug efflux pump present in Mycobacteriumfortuitumand Mycobacterium tuberculosis, J. Bacteriol. 180, 5836-5843.
119. De Rossi, E., Arrigo, P., Bellinzoni, M., Silva, P. A., Martin, C., Ainsa, J. A., Guglierame, P., and Riccardi, G. (2002) The multidrug transporters belonging to major facilitator superfamily in Mycobacterium tuberculosis, Mol. Med. 8, 714-724
120. Viveiros, M., Leandro, C., and Amaral, L. (2003) Mycobacterial efflux pumps and chemotherapeutic implications, Int. J. Antimicrob. Agents 22, 274-278.
121. Siddiqi, N., Das, R., Pathak, N., Banerjee, S., Ahmed, N., Katoch, V. M., and Hasnain, S. E. (2004) Mycobacterium tuberculosis isolate with a distinct genomic identity overexpresses a tap-like efflux pump, Infection 32, 109-111.
122. Silva, P. E., Bigi, F., Santangelo, M. P., Romano, M. I., Martin, C., Cataldi, A., and Ainsa, J. A. (2001) Characterization of P55, a multidrug efflux pump in Mycobacterium bovis and Mycobacterium tuberculosis, Antimicrob. Agents Chemother. 45, 800-804.
123. Goldberg, M., Pribyl, T., Juhnke, S., and Nies, D. H. (1999) Energetics and topology of CzcA, a cation/proton antiporter of the resistance-nodulation-cell division protein family, J. Biol. Chem. 274, 26065-26070.
124. Tseng, T. T., Gratwick, K. S., Kollman, J., Park, D., Niles, D. H., Goffeau, A., and Saier, M. H., Jr. (2003) The RND permease family: an ancient, ubiquitus and diverse family that includes human diseases and development proteins, Mol. Microbiol. Biotechnol. 1, 107-125.
125. Elkins, C. A., and Nikaido, H. (2003) 3D structure of AcrB: the archetypal multidrug efflux transporter of Escherichia coli likely captures substrates from periplasm, Drug Resist. Update 6, 9-13.
126. Mao, W., Warren, M. S., Black, D. S., Satou, T., Murata, T., Nishino, T., Gotoh, N., and Lomovskaya, O. (2002) On the mechanism of substrate specificity by resistance nodulation division (RND)-type multidrug resistance pumps: the large periplasmic loops of MexD from Pseudomonas aeruginosa are involved in substrate recognition, Mol. Microbiol. 46, 889-901.
127. Pos, K. M., and Diederichs, K. (2002) Purification, crystallization and preliminary diffraction studies of AcrB, an inner-membrane multi-drug efflux protein, Acta Crystallogr. 58, 1865-1867.
128. Pos, K. M., Schiefner, A., Seeger, M. A., and Diederichs, K. (2004) Crystallographic analysis of AcrB, FEBS Lett. 564, 333-339.
129. Murakami, S., Nakashima, R., Yamashita, E., and Yamaguchi, A. (2002) Crystal structure of bacterial multidrug efflux transporter AcrB, Nature 419, 587-593.
130. Elkins, C. A., and Nikaido, H. (2002) Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominantly by two large periplasmic loops, J. Bacteriol. 184, 6490-6498.
131. Murakami, S., Nakashima, R., Yamashita, E., Matsumoto, T., and Yamaguchi, A. (2006) Crystal structures of a multidrug transporter reveal a functionally rotating mechanism, Nature 443, 173-179.
132. Seeger, M. A., Schiefner, A., Eicher, T., Verrey, F., Diederichs, K., and Pos, K. M. (2006) Structural asymmetry of AcrB trimer suggests a peristaltic pump mechanism, Science 313, 1295-1298.
133. Seeger, M. A., Diederichs, K., Eicher, T., Brandstatter, L., Schiefner, A., Verrey, F., and Pos, K. M. (2008) The AcrB efflux pump: conformational cycling and peristalsis lead to multidrug resistance, Curr. Drug Targets 9, 729-749.
134. Murakami, S. (2008) Multidrug efflux transporter, AcrB-the pumping mechanism, Curr. Opin. Struct. Biol. 18, 459-465.
135. Pos, K. M. (2009) Drug transport mechanism of the AcrB efflux pump, Biochim. Biophys. Acta 1794, 782-793.
136. Eicher, T., Brandstatter, L., and Pos, K. M. (2009) Structural and functional aspects of the multidrug efflux pump AcrB, Biol. Chem. 390, 693-699.
137. Nikaido, H. (2003) Molecular basis of bacterial outer membrane permeability revisited, Microbiol. Mol. Biol. Rev. 67, 593-656.
138. Nikaido, H., and Takatsuka, Y. (2009) Mechanisms of RND multidrug efflux pumps, Biochim. Biophys. Acta 1794, 769-781.
139. Fralick, J. A., and Burns-Keliher, L. L. (1994) Additive effect of tolC and rfa mutations on the hydrophobic barrier of the outer membrane of Escherichia coli K-12, J. Bacteriol. 176, 6404-6406.
140. Higgins, M. K., Bokma, E., Koronakis, E., Hughes, C., and Koronakis, V. (2004) Structure of the periplasmic component of a bacterial drug efflux pump, Proc. Natl. Acad. Sci. USA 101, 9994-9999.
141. Mikolosko, J., Bobyk, K., Zgurskaya, H. I., and Ghosh, P. (2006) Conformational flexibility in the multidrug efflux system protein AcrA, Structure 14, 577-587.
142. Piao, S., Xu, Y., and Ha, N. C. (2008) Crystallization and preliminary X-ray crystallographic analysis of MacA from Actinobacillus actinomycetemcomitans, Acta Crystallogr. 64, 391-393.
143. Lobedanz, S., Bokma, E., Symmons, M. F., Koronakis, E., Hughes, C., and Koronakis, V. (2007) A periplasmic coiled-coil interface underlying TolC recruitment and the assembly of bacterial drug efflux pumps, Proc. Natl. Acad. Sci. USA 104, 4612-4617.
144. Stegmeier, J. F., Polleichtner, G., Brandes, N., Hotz, C., and Andersen, C. (2006) Importance of the adaptor (membrane fusion) protein hairpin domain for the functionality of multidrug efflux pumps, Biochemistry 45, 10303-10312.
145. Zgurskaya, H. I., Yamada, Y., Tikhonova, E. B., Ge, Q., and Krishnamoorthy, G. (2009) Structural and functional diversity of bacterial membrane fusion proteins, Biochim. Biophys. Acta 1794, 794-807.
146. Koronakis, V., Sharff, A., Koronakis, E., Luisi, B., and Hughes, C. (2000) Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export, Nature 405, 914-919.
147. Akama, H., Kanemaki, M., Tsukihara, T., Nakagawa, A., and Nakae, T. (2005) Preliminary crystallographic analysis of the antibiotic discharge outer membrane lipoprotein OprM of Pseudomonas aeruginosa with an exceptionally long unit cell and complex lattice structure, Acta Crystallogr. 61, 131-133.
148. Federici, L., Du, D., Walas, F., Matsumura, H., Fernández-Recio, J., McKeegan, K. S., Borges-Walmsley, M. I., Luisi, B. F., andWalmsley, A. R. (2005) The crystal structure of the outer membrane protein VceC from the bacterial pathogen Vibrio cholerae at 1.8 A _ resolution, J. Biol. Chem. 280, 15307-15314.
149. Vediyappan, G., and Fralick, J. A. (2009) Unpublished results.
150. Husain, F., Humbard, M., and Misra, R. (2004) Interaction between the TolC and AcrA proteins of a multidrug efflux system of Escherichia coli, J. Bacteriol. 186, 8533-8536.
151. Tikhonova, E. B., and Zgurskaya, H. I. (2004) AcrA, AcrB, and TolC of Escherichia coli form a stable intermembrane multidrug efflux complex, J. Biol. Chem. 279, 32116-32124.
152. Touzé, T., Eswaran, J., Bokma, E., Koronakis, E., Hughes, C., and Koronakis, V. (2004) Interactions underlying assembly of the Escherichia coli AcrAB-TolC multidrug efflux system, Mol. Microbiol. 53, 697-706.
153. Aires, J. R., and Nikaido, H. (2005) Aminoglycosides are captured from both periplasm and cytoplasm by the AcrD multidrug efflux transporter of Escherichia coli, J. Bacteriol. 187, 1923-1929.
154. Fernández-Recio, J., Totrov, M., and Abagyan, R. (2004) Identification of protein- protein interaction sites from docking energy landscapes, J. Mol. Biol. 335, 843-865.
155. Misra, R., and Bavro, V. N. (2009) Assembly and transport mechanism of tripartite drug efflux systems, Biochim. Biophys. Acta 1794, 817-825.
156. Eswaran, J., Koronakis, E., Higgins, M. K., Hughes, C., and Koronakis, V. (2004) Three's company: component structures bring a closer view of tripartite drug efflux pumps, Curr. Opin. Struct. Biol. 14, 741-747.
157. Bavro, V. N., Pietras, Z., Furnham, N., Perez-Cano, L., Fernández-Recio, J., Pei, X. Y., Misra, R., and Luisi, B. (2008) Assembly and channel opening in a bacterial drug efflux machine, Mol. Cell 30, 114-121.
158. Nehme, D., and Poole, K. (2007) Assembly of the MexAB-OprM multidrug pump of Pseudomonas aeruginosa: component interactions defined by the study of pump mutant suppressors, J. Bacteriol. 189, 6118-6127.
159. Koronakis, V., Eswaran, J., and Hughes, C. (2004) Structure and function of TolC: the bacterial exit duct for proteins and drugs, Annu. Rev. Biochem. 73, 467-489.
160. Andersen, C., Koronakis, E., Bokma, E., Eswaran, J., Humphreys, D., Hughes, C., and Koronakis, V. (2002) Transition to the open state of the TolC periplasmic tunnel entrance, Proc. Natl. Acad. Sci. USA 99, 11103-11108.
161. Chollet, R., Chevalier, J., Bryskier, A., and Pages, J. M. (2004) The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli, Antimicrob. Agents Chemother. 48, 3621-3624.
162. Ma, D., Cook, D. N., Alberti, M., Pon, N. G., Nikaido, H., and Hearst, J. E. (1995) Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli, Mol. Microbiol. 16, 45-55.
163. Wandersman, C., and Delepelaire, P. (1990) TolC, an Escherichia coli outer membrane protein required for hemolysin secretion, Proc. Natl. Acad. Sci. USA 87, 4776-4780.
164. Blair, J. M., and Piddock, L. J. (2009) Structure, function and inhibition of RND efflux pumps in gram-negative bacteria: an update, Curr. Opin. Microbiol. 12, 512-519.
165. Fralick, J. A. (1996) Evidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli, J. Bacteriol. 178, 5803-5805.
166. Baucheron, S., Tyler, S., Boyd, D., Mulvey, M. R., Chaslus-Dancla, E., and Cloeckaert, A. (2004) AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar typhimurium DT104, Antimicrob. Agents Chemother. 48, 3729-3735.
167. Jellen-Ritter, A. S., and Kern, W. V. (2001) Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with insertion element transposition in Escherichia coli mutants selected with a fluoroquinolone, Antimicrob. Agents Chemother. 45, 1467-1472.
168. Schweizer, H. P. (1998) Intrinsic resistance to inhibitors of fatty acid biosynthesis in Pseudomonas aeruginosa is due to efflux: application of a novel technique for generation of unmarked chromosomal mutations for the study of efflux systems, Antimicrob. Agents Chemother. 42, 394-398.
169. Chuanchuen, R., Beinlich, K., Hoang, T. T., Becher, A., Karkhoff-Schweizer, R. R., and Schweizer, H. P. (2001) Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ, Antimicrob. Agents Chemother. 45, 428-432.
170. Chuanchuen, R., Narasaki, C. T., and Schweizer, H. P. (2002) The MexJK efflux pump of Pseudomonas aeruginosa requires OprM for antibiotic efflux but not for efflux of triclosan, J. Bacteriol. 184, 5036-5044.
171. Morita, Y., Sobel, M. L., and Poole, K. (2006) Antibiotic inducibility of the MexXY multidrug efflux system of Pseudomonas aeruginosa: involvement of the antibioticinducible PA5471 gene product, J. Bacteriol. 188, 1847-1855.
172. Sekiya, H., Mima, T., Morita, Y., Kuroda, T., Mizushima, T., and Tsuchiya, T. (2003) Functional cloning and characterization of amultidrug efflux pump,MexHI-OpmD, froma Pseudomonas aeruginosa mutant, Antimicrob. Agents Chemother. 47, 2990-2992.
173. Li, Y., Mima, T., Komori, Y., Morita, Y., Kuroda, T., Mizushima, T., and Tsuchiya, T. (2003) A new member of the tripartite multidrug efflux pumps, MexVW-OprM, in Pseudomonas aeruginosa, J. Antimicrob. Chemother. 52, 572-575.
174. Chang, L. L., Chen, H. F., Chang, C. Y., Lee, T. M., andWu,W. J. (2004) Contribution of integrons and SmeABC and SmeDEF efflux pumps to multidrug resistance in clinical isolates of Stenotrophomonas maltophilia, J. Antimicrob. Chemother. 53, 518-521.
175. Pumbwe, L., Randall, L. P., Woodward, M. J., and Piddock, L. J. (2004) Expression of the efflux pump genes cmeB, cmeF and the porin gene porA in multiple-antibioticresistant Campylobacter jejuni, J. Antimicrob. Chemother. 54, 341-347.
176. Kumar, A., and Worobec, E. A. (2005) Cloning, sequencing, and characterization of the SdeAB multidrug efflux pump of Serratia marcescens, Antimicrob. Agents Chemother. 49, 1495-1501.
177. Chen, J., Kuroda, T., Huda, M. N., Mizushima, T., and Tsuchiya, T. (2003) An RND-type multidrug efflux pump SdeXY from Serratia marcescens, J. Antimicrob. Chemother. 52, 176-179.
178. Zarantonelli, L., Borthagaray, G., Lee, E. H., and Shafer, W. M. (1999) Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations, Antimicrob. Agents Chemother. 43, 2468-2472.
179. Cousin, S. L., Jr., Whittington, W. L., and Roberts, M. C. (2003) Acquired macrolide resistance genes and the 1 bp deletion in the mtrR promoter in Neisseria gonorrhoeae, J. Antimicrob. Chemother. 51, 131-133.
180. Dewi, B. E., Akira, S., Hayashi, H., and Ba-Thein, W. (2004) High occurrence of simultaneous mutations in target enzymes and MtrRCDE efflux system in quinoloneresistant Neisseria gonorrhoeae, Sex. Transm. Dis. 31, 353-359.
181. Nair, B. M., Cheung, K. J., Jr., Griffith, A., and Burns, J. L. (2004) Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia), J. Clin. Invest. 113, 464-473.
182. Kaczmarek, F. S., Gootz, T. D., Dib-Hajj, F., Shang, W., Hallowell, S., and Cronan, M. (2004) Genetic and molecular characterization of beta-lactamase-negative ampicillinresistant Haemophilus influenzae with unusually high resistance to ampicillin, Antimicrob. Agents Chemother. 48, 1630-1639.
183. Magnet, S., Courvalin, P., and Lambert, T. (2001) Resistance-nodulation-cell division--type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454, Antimicrob. Agents Chemother. 45, 3375-3380.
184. Saier, M. H., Jr., Tran, C., and Barabote, R. D. (2006) TCDB: The transporter classification database for membrane transport protein analyses and information, Nucleic Acids Res. 34, D191-D186.
185. Barabote, R. D., Rendulic, S., Schuster, S. C., and Saier,M. H., Jr. (2007) Comprehensive analysis of transport proteins encoded within the genome of Bdellovibrio bacteriovorus, Genomics 90, 424-446.
186. Barabote, R. D., and Saier, M. H., Jr. (2005) Comparative genomic analyses of the bacterial phosphotransferase system, Microbiol. Mol. Biol. Rev. 69, 608-634.
187. Schneiker, S., Perlova, O., Kaiser, O., Gerth, K., Alici, A., Altmeyer, M.O., Bartels, D., Bekel, T., Beyer, S., Bode, E., et al. (2007) Complete genome sequence of the Myxobacterium sorangium cellulosum, Nat. Biotechnol. 25, 1281-1289.
188. McCutcheon, J. P., and Moran, N. A. (2007) Parallel genomic evolution and metabolic interdependence in an ancient symbiosis, Proc. Natl. Acad. Sci. USA 104, 19392-19397.
189. Lorca, G. L., Barabote, R. D., Zlotopolski, V., Tran, C., Winnen, B., Hvorup, R. N., Stonestrom, A. J., Nguyen, E., Huang, L. W., Kim, D. S., and Saier, M. H., Jr. (2007) Transport capabilities of eleven gram-positive bacteria: comparative genomic analyses, Biochim. Biophys. Acta, 1768, 1342-1366.
190. Nagata, Y., Matsuda, M., Komatsu, H., Imura, Y., Sawada, H., Ohtsubo, Y., and Tsuda, M. (2005) Organization and localization of the dnaA and dnaK gene regions on themultichromosomal genome of Burkholderia multivorans ATCC 17616, J. Biosci. Bioeng. 99, 603-610.
191. Zahariadis, G., Levy, M. H., and Burns, J. L. (2003) Cepacia-like syndrome caused by Burkholderia multivorans, Can. J. Infect. Dis., 14, 123-125.
192. Horn, M., Harzenetter, M. D., Linner, T., Schmid, E. N., Müller, K. D., Michel, R., and Wagner, M. (2001) Members of the Cytophaga-Flavobacterium-Bacteroides phylum as intracellularbacteria of acanthamoebae: proposal of " Candidatus amoebophilus asiaticus," Environ. Microbiol. 3, 440-449.
193. Wu, D., Daugherty, S., Van Aken, S. E., Pai, G. H.,Watkins, K. L., Khouri, H., Tallon, L. J., Zaborsky, J. M., Dunbar, H. E., Tran, P. L., Moran, N. A., and Eisen, J. (2006) Metabolic complementarity and genomics of the dual bacterial symbiosis of sharpshooters, PLoS Biol. 4, e188.
194. Raymond, J. C., and Sistrom, W. R. (1969) Ectothiorhodospirahalophila: a new species of the genus, Ectothiorhodospira Arch. Mikrobiol. 69, 121-126.
195. Kapatral, V., Anderson, I., Ivanova, N., Reznik, G., Los, T., Lykidis, A., Bhattacharyya, A., Bartman, A., Gardner,W., Grechkin, G., et al. (2002) Genome sequence and analysis of the oralbacterium Fusobacterium nucleatum strain ATCC 25586, J. Bacteriol. 184, 2005-2018.
196. Albertson, G. D., Niimi, M., Cannon, R. D., and Jenkinson, H. F. (1996) Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance, Antimicrob. Agents Chemother. 40, 2835-2841.
197. Lamping, E., Monk, B. C., Niimi, K., Holmes, A. R., Tsao, S., Tanabe, K., Niimi, M., Uehara, Y., and Cannon, R. D. (2007) Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae, Eukaryot. Cell 6, 1150-1165.
198. Griffin, D. H. (1994) Fungal Physiology, 2nd ed., Wiley-Liss, New York.
199. Saville, S. P., Lazzell, A. L., Monteagudo, C., and Lopez-Ribot, J. L. (2003) Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection, Eukaryot. Cell 2, 1053-1060.
200. Kim, S., Kim, E., Shin, D. S., Kang, H., and Oh, K. B. (2002) Evaluation of morphogenic regulatory activity of farnesoic acid and its derivatives against Candida albicans dimorphism, Bioorg. Med. Chem. Lett. 12, 895-898.
201. Nunes, L. R., Costa de Oliveira, R., Leite, D. B., da Silva, V. S., dos Reis Marques, E., da Silva Ferreira, M. E., Ribeiro, D. C., de Souza Bernardes, L. A., Goldman, M. H., Puccia, R., et al. (2005) Transcriptome analysis of Paracoccidioides brasiliensis cells undergoing mycelium-to-yeast transition, Eukaryot. Cell 4, 2115-2128.
202. Campos, C. B., Di Benedette, J. P., Morais, F. V., Ovalle, R., and Nobrega, M. P. (2008) Evidence for the role of calcineurin in morphogenesis and calcium homeostasis during mycelium-to-yeast dimorphism of Paracoccidioides brasiliensis, Eukaryot. Cell 7, 1856-1864.
203. Moss, A. S., Reddy, N. S., Dortaj, I. M., and San Francisco, M. J. (2008) Chemotaxis of the amphibian pathogen Batrachochytrium dendrobatidis and its response to a variety of attractants, Mycologia 100, 1-5.
204. Pfaller, M. A., and Diekema, D. J. (2004) Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus, J. Clin. Microbiol. 42, 4419-4431.
205. Blehert, D. S., Hicks, A. C., Behr, M., Meteyer, C. U., Berlowski-Zier, B. M., Buckles, E. L., Coleman, J. T., Darling, S. R., Gargas, A., Niver, R., et al. (2009) Bat white-nose syndrome: an emerging fungal pathogen? Science 323, 227.
206. Longcore, J. E., Pessier, A. P., and Nichols, D. K. (1999) Batrachochytrium dendrobatidis gen et sp nov, a chytrid pathogenic to amphibians, Mycologia 91, 219-227.
207. Gulshan, K., and Moye-Rowley, W. S. (2007) Multidrug resistance in fungi, Eukaryot. Cell 6, 1933-1942.
208. Anderson, J. B. (2005) Evolution of antifungal-drug resistance: mechanisms and pathogen fitness, Nat. Rev. Microbiol. 3, 547-556.
209. Podust, L. M., von Kries, J. P., Eddine, A. N., Kim, Y., Yermalitskaya, L. V., Kuehne, R., Ouellet, H., Warrier, T., Altekoster, M., Lee, J. S., Rademann, J., Oschkinat, H., Kaufmann, S. H., and Waterman, M. R. (2007) Small-molecule scaffolds for CYP51 inhibitors identified by high-throughput screening and defined by x-ray crystallography, Antimicrob. Agents Chemother. 51, 3915-3923.
210. Talele, T. T., and Kulkarni, V. M. (1999) Three-dimensional quantitative structure- activity relationship (QSAR) and receptor mapping of cytochrome P-450 (14 alpha DM) inhibiting azole antifungal agents, J. Chem. Inf. Comput. Sci. 39, 204-210.
211. Che, X., Sheng, C., Wang, W., Cao, Y., Xu, Y., Ji, H., Dong, G., Miao, Z., Yao, J., and Zhang, W. (2009) New azoles with potent antifungal activity: design, synthesis and molecular docking, Eur. J. Med. Chem. 44, 4218-4226.
212. Mota, C. R., Miranda, K. C., Lemos J. de, A., Costa, C. R., Hasimoto e Souza, L. K., Passos, X. S., Meneses e Silva, H., and Silva M. do, R. (2009) Comparison of in vitro activity of five antifungal agents against dermatophytes, using the agar dilution and broth microdilution methods, Rev. Soc. Bras. Med. Trop. 42, 250-254.
213. Cowen, L. E., and Steinbach, W. J. (2008) Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance, Eukaryot. Cell 7, 747-764.
214. Kauffman, C. A. (2006) Clinical efficacy of new antifungal agents, Curr. Opin. Microbiol. 9, 483-488.
215. Odds, F. C., Brown, A. J., and Gow, N. A. (2003) Antifungal agents: mechanisms of action, Trends Microbiol. 11, 272-279.
216. Chapman, S. W., Sullivan, D. C., and Cleary, J. D. (2008) In search of the holy grail of antifungal therapy, Trans. Am. Clin. Climatol. Assoc. 119, 197-215; discussion 215-196.
217. Tincu, J. A., and Taylor, S. W. (2004) Antimicrobial peptides from marine invertebrates, Antimicrob. Agents Chemother. 48, 3645-3654.
218. Jenssen, H., Hamill, P., and Hancock, R. E. (2006) Peptide antimicrobial agents. Clin. Microbiol. Rev. 19, 491-511.
219. Ghannoum, M. A., and Rice, L. B. (1999) Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance, Clin. Microbiol. Rev. 12, 501-517.
220. Ren, Q., Chen, K., and Paulsen, I. T. (2007) TransportDB: a comprehensive database resource for cytoplasmic membrane transport systems and outer membrane channels, Nucleic Acids Res. 35, D274-D279.
221. Morrissey, J. P., and Osbourn, A. E. (1999) Fungal resistance to plant antibiotics as a mechanism of pathogenesis, Microbiol. Mol. Biol. Rev. 63, 708-724.
222. Saier, M. H., Jr. (1998) Molecular phylogeny as a basis for the classification of transport proteins from bacteria, archaea and eukarya, Adv. Microb. Physiol. 40, 81-136.
223. Souid, A. K., Gao, C.,Wang, L., Milgrom, E., and Shen,W. C. (2006) ELM1 is required for multidrug resistance in Saccharomyces cerevisiae, Genetics 173, 1919-1937.
224. Schmitt, L., and Tampe, R. (2002) Structure and mechanism of ABC transporters, Curr. Opin. Struct. Biol. 12, 754-760.
225. Jungwirth, H., and Kuchler, K. (2006) Yeast ABC transporters-a tale of sex, stress, drugs and aging, FEBS Lett. 580, 1131-1138.
226. Piddock, L. J. (2006) Multidrug-resistance efflux pumps-not just for resistance, Nat. Rev. Microbiol. 4, 629-636.
227. Walker, J. E., Saraste, M., Runswick, M. J., and Gay, N. J. (1982) Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold, EMBO J. 1, 945-951.
228. Decottignies, A., and Goffeau, A. (1997) Complete inventory of the yeast ABC proteins, Nat. Genet. 15, 137-145.
229. Coleman, J. J., and Mylonakis, E. (2009) Efflux in fungi: la pi_ece de r_esistance, PLoS Pathog. 5, e1000486.
230. Sipos, G., and Kuchler, K. (2006) Fungal ATP-binding cassette (ABC) transporters in drug resistance and detoxification, Curr. Drug Targets 7, 471-481.
231. Rogers, B. D. A., Kolaczkowski, M., Carvajal, E., Balzi, E., and Goffeau, A. (2003) The pleitropic drug ABC transporters from Saccharomyces cerevisiae, J. Mol. Microbiol. Biotechnol. 3, 207-214.
232. Iwaki, T., Giga-Hama, Y., and Takegawa, K. (2006) A survey of all 11 ABC transporters in fission yeast: two novel ABC transporters are required for red pigment accumulation in a Schizosaccharomyces pombe adenine biosynthetic mutant, Microbiology 152, 2309-2321.
233. Rea, P. A. (2007) Plant ATP-binding cassette transporters, Annu. Rev. Plant Biol. 58, 347-375.
234. Bauer, B. E., Wolfger, H., and Kuchler, K. (1999) Inventory and function of yeast ABC proteins: about sex, stress, pleiotropic drug and heavy metal resistance, Biochim. Biophys. Acta 1461, 217-236.
235. Rogers, B., Decottignies, A., Kolaczkowski, M., Carvajal, E., Balzi, E., and Goffeau, A. (2001) The pleitropic drug ABC transporters from Saccharomyces cerevisiae, J. Mol. Microbiol. Biotechnol. 3, 207-214.
236. Kralli, A., Bohen, S. P., and Yamamoto, K. R. (1995) LEM1, an ATP-binding-cassette transporter, selectively modulates the biological potency of steroid hormones, Proc. Natl. Acad. Sci. USA 92, 4701-4705.
237. Bissinger, P. H., and Kuchler, K. (1994) Molecular cloning and expression of the Saccharomyces cerevisiae STS1 gene product: a yeast ABC transporter conferring mycotoxin resistance, J. Biol. Chem. 269, 4180-4186.
238. Garcia-Effron, G., Dilger, A., Alcazar-Fuoli, L., Park, S., Mellado, E., and Perlin, D. S. (2008) Rapid detection of triazole antifungal resistance in Aspergillus fumigatus, J. Clin. Microbiol. 46, 1200-1206.
239. da Silva Ferreira, M. E., Capellaro, J. L., dos Reis Marques, E., Malavazi, I., Perlin, D., Park, S., Anderson, J. B., Colombo, A. L., Arthington-Skaggs, B. A., Goldman, M. H., and Goldman, G. H. (2004) In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple mechanisms of resistance, Antimicrob. Agents Chemother. 48, 4405-4413.
240. Tobin, M. B., Peery, R. B., and Skatrud, P. L. (1997) Genes encoding multiple drug resistance-like proteins in Aspergillus fumigatus and Aspergillus flavus, Gene 200, 11-23.
241. Del Sorbo, G., Andrade, A. C., Van Nistelrooy, J. G., Van Kan, J. A., Balzi, E., and De Waard, M. A. (1997) Multidrug resistance in Aspergillus nidulans involves novel ATP-binding cassette transporters, Mol. Gen. Genet. 254, 417-426.
242. Semighini, C. P., Marins, M., Goldman, M. H., and Goldman, G. H. (2002) Quantitative analysis of the relative transcript levels of ABC transporter Atr genes in Aspergillus nidulans by real-time reverse transcription-PCR assay, Appl. Environ. Microbiol. 68, 1351-1357.
243. Pappas, P. G., Rex, J. H., Lee, J., Hamill, R. J., Larsen, R. A., Powderly,W., Kauffman, C. A., Hyslop, N., Mangino, J. E., Chapman, S., et al., and NIAID Mycoses Study Group (2003) A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients, Clin. Infect. Dis. 37, 634-643.
244. Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H.,Wenzel, R. P., and Edmond, M. B. (2009) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study, Clin. Infect. Dis. 49, 699-701.
245. Tsao, S., Rahkhoodaee, F., and Raymond, M. (2009) Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance, Antimicrob. Agents Chemother. 53, 1344-1352.
246. Holmes, A. R., Lin, Y. H., Niimi, K., Lamping, E., Keniya, M., Niimi, M., Tanabe, K., Monk, B. C., and Cannon, R. D. (2008) ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates, Antimicrob. Agents and Chemother. 52, 3851-3862.
247. Prasad, R. K. S., Prasad, R., Gupta, V., and Lata, S. (1996) Multidrug resistance: an emerging threat, Curr. Sci. 71, 205-213.
248. Shukla, S., Saini, P., Smriti, Jha, S., Ambudkar, S. V., and Prasad, R. (2003) Functional characterization of Candida albicans. ABC transporter Cdr1p, Eukaryot. Cell 2, 1361-1375.
249. Jha, S., Karnani, N., Lynn, A. M., and Prasad, R. (2003) Covalent modification of cysteine 193 impairs ATPase function of nucleotide-binding domain of a Candida drug efflux pump, Biochem. Biophys. Res. Commun. 310, 869-875.
250. Jha, S., Dabas, N., Karnani, N., Saini, P., and Prasad, R. (2004) ABC multidrug transporter Cdr1p of Candida albicans has divergent nucleotide-binding domains which display functional asymmetry, FEMS Yeast Res. 5, 63-72.
251. Prasad, R., Gaur, N. A., Gaur, M., and Komath, S. S. (2006) Efflux pumps in drug resistance of Candida, Infect. Disord. Drug Targets 6, 69-83.
252. Shukla, S., Rai, V., Saini, P., Banerjee, D., Menon, A. K., and Prasad, R. (2007) Candida drug resistance protein 1, a major multidrug ATP binding cassette transporter of Candida albicans, translocates fluorescent phospholipids in a reconstituted system, Biochemistry 46, 12081-12090.
253. Clark, F. S., Parkinson, T., Hitchcock, C. A., and Gow, N. A. (1996) Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance, Antimicrob. Agents Chemother. 40, 419-425.
254. Niimi, K., Maki, K., Ikeda, F., Holmes, A. R., Lamping, E., Niimi, M., Monk, B. C., and Cannon, R. D. (2006) Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility, Antimicrob. Agents Chemother. 50, 1148-1155.
255. Moran, G., Sullivan, D., Morschhauser, J., and Coleman, D. (2002) The Candida dubliniensis CdCDR1 gene is not essential for fluconazole resistance, Antimicrob. Agents Chemother. 46, 2829-2841.
256. Chen,W. J., Delmotte, F., Richard-Cervera, S., Douence, L., Greif, C., and Corio-Costet, M. F. (2007) At least two origins of fungicide resistance in grapevine downy mildew populations, Appl. Environ. Microbiol. 73, 5162-5172.
257. Reimann, S., and Deising, H. B. (2005) Inhibition of efflux transporter-mediated fungicide resistance in Pyrenophora tritici-repentis by a derivative of 40-hydroxyflavone and enhancement of fungicide activity, Appl. Environ. Microbiol. 71, 3269-3275.
258. Leonard, K. J., Anikster, Y., and Manisterski, J. (2005) Virulence associations in oat crown rust, Phytopathology 95, 53-61.
259. Urban, M., Bhargava, T., and Hamer, J. E. (1999) An ATP-driven efflux pump is a novel pathogenicity factor in rice blast disease, EMBO J. 18, 512-521.
260. Sun, C. B., Suresh, A., Deng, Y. Z., and Naqvi, N. I. (2006) A multidrug resistance transporter in Magnaporthe is required for host penetration and for survival during oxidative stress, Plant Cell 18, 3686-3705.
261. Chen, C. G., Yang, Y. L., Tseng, K. Y., Shih, H. I., Liou, C. H., Lin, C. C., and Lo, H. J. (2009) Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans, Fungal Genet. Biol. 46, 714-720.
262. Zwiers, L. H., Stergiopoulos, I., Van Nistelrooy, J. G., and DeWaard, M. A. (2002) ABC transporters and azole susceptibility in laboratory strains of the wheat pathogen Mycosphaerella graminicola, Antimicrob. Agents Chemother. 46, 3900-3906.
263. Vermeulen, T., Schoonbeek, H., and De Waard, M. A. (2001) The ABC transporter BcatrB from Botrytis cinerea is a determinant of the activity of the phenylpyrrole fungicide fludioxonil. Pest Mang. Sci. 57, 393-402.
264. Hof, H. (2001) Critical annotations to the use of azole antifungals for plant protection, Antimicrob. Agents Chemother. 45, 2987-2990.
265. Berger, L., Speare, R., and Kent, A. (1999) Diagnosis of chytridiomycosis in amphibians by histologic examination. Proc. Frog Symposium: Frogs in the Community, Queensland Museum, Brisbane, Australia.
266. Harvey, P. H., and Pagel, M. D. (1991). The Comparative Method in Evolutionary Biology, Oxford University Press, Oxford, UK.
267. Larson, A., and Losos, J. B. (1996) Phylogenetic systematics of adaptation, in Adaptation, Rose, M. R., and Lauder, G. V., Eds., Academic Press, San Diego, CA, pp. 187-220.
268. Martins, E. (2000) Adaptation and the comparative method, Trends Ecol. Evol. 15, 296-299.
269. Robbertse, B., Reeves, J. B., Schoch, C. L., and Spatafora, J. W. (2006) A phylogenomic analysis of the Ascomycota, Fungal Genet. Biol. 43, 715-725.
270. Suh, S. O., Blackwell, M., Kurtzman, C. P., and Lachance, M. A. (2006) Phylogenetics of Saccharomycetales, the ascomycete yeasts, Mycologia 98, 1006-1017.
271. Geiser, D.M., Gueidan, C., Miadlikowska, J., Lutzoni, F., Kauff, F., Hofstetter, V., Fraker, E., Schoch, C. L., Tibell, L., Untereiner, W. A., and Aptroot, A. (2006) Eurotiomycetes: Eurotiomycetidae and Chaetothyriomycetidae, Mycologia 98, 1053-1064.
272. Fitzpatrick, D. A., Logue, M. E., Stajich, J. E., and Butler, G. (2006) A fungal phylogeny based on 42 complete genomes derived from supertree and combined gene analysis, BMC Evol. Biol. 6, 99.
273. Soanes, D. M., Richards, T. A., and Talbot, N. J. (2007) Insights from sequencing fungal and oomycete genomes: What can we learn about plant disease and the evolution of pathogenicity? Plant Cell 19, 3318-3326.
274. Podani, J., Engloner, A., and Major, A. (2009) Multilevel comparison of dendrograms: a new method with an application for genetic classifications, Stat. Appl. Genet. Mol. Biol. 8, 1-14.
275. Thompson, J. D., Higgins, D. G., and Gibson, T. J. (1994) CLUSTALW: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice, Nucleic Acids Res. 22, 4673-4680.
276. Nei, M., and Kumar, S. (2000) Molecular Evolution and Phylogenetics, Oxford University Press, New York.
277. Felsenstein, J. (1985) Confidence limits on phylogenies: an approach using the bootstrap, Evolution 39, 783-791.
278. Eck, R. V. a. M. O. D. (1966) Atlas of Protein Sequences and Structure, National Biomedical Research Foundation, Silver Springs, MD.
279. Tamura, K., Dudley, J., Nei, M., and Kumar, S. (2007) MEGA4: Molecular Evolutionary genetics analysis (MEGA), software version 4.0, Mol. Biol. Evol. 24, 1596-1599.
280. + antiporters in chemical stress response in yeast, Trends Microbiol. 17, 22-31.
281. Ehrenhofer-Murray, A. E., Wurgler, F. E., and Sengstag, C. (1994) The Saccharomyces cerevisiae SGE1 gene product: a novel drug-resistance protein within the major facilitator superfamily, Mol. Gen. Genet. 244, 287-294.
282. Felder, T., Bogengruber, E., Tenreiro, S., Ellinger, A., Sa-Correia, I., and Briza, P. (2002) Dtrlp, a multidrug resistance transporter of the major facilitator superfamily, plays an essential role in spore wall maturation in Saccharomyces cerevisiae, Eukaryot. Cell 1, 799-810.
283. Jenkins, C. C., Mata, J., Crane, R. F., Thomas, B., Akoulitchev, A., Bahler, J., and Norbury, C. J. (2005) Activation of AP-1-dependent transcription by a truncated translation initiation factor, Eukaryot. Cell 4, 1840-1850.
284. Calvo, I. A., Gabrielli, N. G., Iglesias-Baena, I., Garcia-Santamarina, S., Hoe, K. L., Kim D. U., Sanso' M., M. Zuin A., Pérez, P., Ayté, J., and Hidalgo, E. (2009) Genome-wide screen of genes required for caffeine tolerance in fission yeast, PLoS One 4, e6619.
285. Nascimento, A. M., Goldman, G. H., Park, S., Marras, S. A., Delmas, G., Oza, U., Lolans, K., Dudley, M. N., Mann, P. A., and Perlin, D. S. (2003) Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole, Antimicrob. Agents Chemother. 47, 1719-1726.
286. Lechenne, B., Reichard, U., Zaugg, C., Fratti, M., Kunert, J., Boulat, O., and Monod, M. (2007) Sulphite efflux pumps in Aspergillus fumigatus and dermatophytes, Microbiology 153, 905-913.
287. Gaur, M., Puri, N., Manoharlal, R., Rai, V., Mukhopadhayay, G., Choudhury, D., and Prasad, R. (2008) MFS transportome of the human pathogenic yeast Candida albicans, BMC Genom. 9, 579.
288. Fling, M. E., Kopf, J., Tamarkin, A., Gorman, J. A., Smith, H. A., and Koltin, Y. (1991) Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate, Mol. Gen. Genet. 227, 318-329.
289. Ben-Yaacov, R., Knoller, S., Caldwell, G. A., Becker, J. M., and Koltin, Y. (1994) Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene, Antimicrob. Agents Chemother. 38, 648-652.
290. Goldway, M., Teff, D., Schmidt, R., Oppenheim, A. B., and Koltin, Y. (1995) Multidrug resistance in Candida albicans: disruption of the BENr gene, Antimicrob. Agents Chemother. 39, 422-426.
291. Cheng, S., Clancy, C. J., Nguyen, K. T., Clapp,W., and Nguyen, M. H. (2007) A Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole, Antimicrob. Agents Chemother. 51, 1855-1858.
292. Becker, J. M., Henry, L. K., Jiang, W., and Koltin, Y. (1995) Reduced virulence of Candida albicans mutants affected in multidrug resistance, Infect. Immun. 63, 4515-4518.
293. + transport, Eukaryot. Cell 6, 443-453.
294. Calabrese, D., Bille, J., and Sanglard, D. (2000) A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole, Microbiology 146(Pt. 11), 2743-2754.
295. Sengupta, M., and Datta, A. (2003) Two membrane proteins located in the Nag regulon of Candida albicans confer multidrug resistance, Biochem. Biophys. Res. Commun. 301, 1099-1108.
296. White, T. C., Holleman, S., Dy, F., Mirels, L. F., and Stevens, D. A. (2002) Resistance mechanisms in clinical isolates of Candida albicans, Antimicrob. Agents Chemother. 46, 1704-1713.
297. Hayashi, K., Schoonbeek, H. J., and De Waard, M. A. (2002) Bcmfs1, a novel major facilitator superfamily transporter from Botrytis cinerea, provides tolerance towards the natural toxic compounds camptothecin and cercosporin and towards fungicides, Appl. Environ. Microbiol. 68, 4996-5004.
298. Roohparvar, R., De Waard, M. A., Kema, G. H., and Zwiers, L. H. (2007) MgMfs1, a major facilitator superfamily transporter from the fungal wheat pathogen Mycosphaerella graminicola, is a strong protectant against natural toxic compounds and fungicides, Fungal Genet. Biol. 44, 378-388.
299. Roohparvar, R., Mehrabi, R., Van Nistelrooy, J. G., Zwiers, L. H., and De Waard, M. A. (2008) The drug transporter MgMfs1 can modulate sensitivity of field strains of the fungal wheat pathogen Mycosphaerella graminicola to the strobilurin fungicide trifloxystrobin, Pest Mang. Sci. 64, 685-693.
300. Coste, A., Turner, V., Ischer, F., Morschhauser, J., Forche, A., Selmecki, A., Berman, J., Bille, J., and Sanglard, D. (2006) A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans, Genetics 172, 2139-2156.
301. Liu, T. T., Znaidi, S., Barker, K. S., Xu, L., Homayouni, R., Saidane, S.,Morschhauser, J., Nantel, A., Raymond, M., and Rogers, P. D. (2007) Genome-wide expression and location analyses of the Candida albicans Tac1p regulon, Eukaryot. Cell 6, 2122-2138.
302. Sellam, A., Tebbji, F., and Nantel, A. (2009) Role of Ndt80p in sterol metabolism regulation and azole resistance in Candida albicans, Eukaryot. Cell 8, 1174-1183.
303. Morschhauser, J., Barker, K. S., Liu, T. T., Bla, B.W. J., Homayouni, R., and Rogers, P. D. (2007) The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans, PLoS Pathog. 3, e164.
304. Harry, J. B., Oliver, B. G., Song, J. L., Silver, P. M., Little, J. T., Choiniere, J., and White, T. C. (2005) Drug-induced regulation of the MDR1 promoter in Candida albicans, Antimicrob. Agents Chemother. 49, 2785-2792.
305. Riggle, P. J., and Kumamoto, C. A. (2006) Transcriptional regulation of MDR1, encoding a drug efflux determinant, in fluconazole-resistant Candida albicans strains through an Mcm1p binding site, Eukaryot. Cell 5, 1957-1968.
306. Znaidi, S., Weber, S., Al-Abdin, O. Z., Bomme, P., Saidane, S., Drouin, S., Lemieux, S., De Deken, X., Robert, F., and Raymond, M. (2008) Genomewide location analysis of Candida albicans Upc2p, a regulator of sterol metabolism and azole drug resistance, Eukaryot. Cell 7, 836-847.
307. Ferrari, S., Ischer, F., Calabrese, D., Posteraro, B., Sanguinetti, M., Fadda, G., Rohde, B., Bauser, C., Bader, O., and Sanglard, D. (2009) Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence, PLoS Pathog. 5, e1000268.
308. Kolaczkowska, A., Kolaczkowski, M., Goffeau, A., and Moye-Rowley, W. S. (2008) Compensatory activation of the multidrug transporters Pdr5p, Snq2p, and Yor1p by Pdr1p in Saccharomyces cerevisiae, FEBS Lett. 582, 977-983.
309. Niimi, K., Harding, D. R., Parshot, R., King, A., Lun, D. J., Decottignies, A., Niimi, M., Lin, S., Cannon, R. D., Goffeau, A., and Monk, B. C. (2004) Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative, Antimicrob. Agents Chemother. 48, 1256-1271.
310. Zhang, H., Gao, A., Li, F., Zhang, G., Ho, H. I., and Liao,W. (2009) Mechanism of action of tetrandrine, a natural inhibitor of Candida albicans drug efflux pumps, Yakugaku Zasshi 129, 623-630.
311. Diwischek, F., Morschhauser, J., and Holzgrabe, U. (2009) Cerulenin analogues as inhibitors of efflux pumps in drug-resistant Candida albicans, Arch. Pharm. (Weinheim) 342, 150-164.
312. Sharma, M., Manoharlal, R., Shukla, S., Puri, N., Prasad, T., Ambudkar, S. V., and Prasad, R. (2009) Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals, Antimicrob. Agents Chemother. 53, 3256-3265.
313. Costerton, J. W., Lewandowski, Z., Caldwell, D. E., Korber, D. R., and Lappin-Scott, H. M. (1995) Microbial biofilms, Annu. Rev. Microbiol. 49, 711-745.
314. Seidler, M. J., Salvenmoser, S., and Muller, F. M. (2008) Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells, Antimicrob. Agents Chemother. 52, 4130-4136.
315. Jabra-Rizk, M. A., Falkler, W. A., and Meiller, T. F. (2004) Fungal biofilms and drug resistance, Emerg. Infect. Dis. 10, 14-19.
316. Kumamoto, C. A. (2002) Candida biofilms, Curr. Opin. Microbiol. 5, 608-611.
317. d'Enfert, C. (2006) Biofilms and their role in the resistance of pathogenic Candida to antifungal agents, Curr. Drug Targets 7, 465-670.
318. Mukherjee, P.K., Chandra, J., Kuhn, D. M., and Ghannoum, M. A. (2003) Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols, Infect. Immun. 71, 4333-4340.
319. Ramage, G., Bachmann, S., Patterson, T. F.,Wickes, B. L., and López-Ribot, J. L. (2002) Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms, J. Antimicrob. Chemother. 49, 973-980.
320. Perumal, P., Mekala, S., and Chaffin,W. L. (2007) Role for cell density in antifungal drug resistance in Candida albicans biofilms, Antimicrob. Agents Chemother. 51, 2454-2463.
321. Chaffin,W. L. (2008) Candida albicans cell wall proteins, Microbiol. Mol. Biol. Rev. 72, 495-544.